Browsing Sykehuset Innlandet HF by Journals "Journal of Internal Medicine"
Now showing items 1-2 of 2
-
Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial
(Journal article; Peer reviewed, 2019)BACKGROUND AND OBJECTIVES: The 52-week, randomized, double-blind, noninferiority, government-funded NOR-SWITCH trial demonstrated that switching from infliximab originator to less expensive biosimilar CT-P13 was not ... -
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
(Peer reviewed; Journal article, 2022)Background: Although coronavirus disease 2019 (COVID-19) is primarily a respiratory infection, mounting evidence suggests that the gastrointestinal (GI) tract is involved in the disease, with gut barrier dysfunction and ...